119 related articles for article (PubMed ID: 26299617)
1. Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.
Punt S; Corver WE; van der Zeeuw SA; Kielbasa SM; Osse EM; Buermans HP; de Kroon CD; Jordanova ES; Gorter A
Oncotarget; 2015 Nov; 6(36):38681-94. PubMed ID: 26299617
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
3. Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer.
Punt S; Houwing-Duistermaat JJ; Schulkens IA; Thijssen VL; Osse EM; de Kroon CD; Griffioen AW; Fleuren GJ; Gorter A; Jordanova ES
Mol Cancer; 2015 Mar; 14():71. PubMed ID: 25889974
[TBL] [Abstract][Full Text] [Related]
4. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
5. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data.
Hou P; Luo Y; Wu N
Open Life Sci; 2023; 18(1):20220707. PubMed ID: 37791059
[TBL] [Abstract][Full Text] [Related]
6. Identification of TCL1A as an immunohistochemical marker of adverse outcome in diffuse large B-cell lymphomas.
Ramuz O; Bouabdallah R; Devilard E; Borie N; Groulet-Martinec A; Bardou VJ; Brousset P; Bertucci F; Birg F; Birnbaum D; Xerri L
Int J Oncol; 2005 Jan; 26(1):151-7. PubMed ID: 15586235
[TBL] [Abstract][Full Text] [Related]
7. FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma.
Punt S; van Vliet ME; Spaans VM; de Kroon CD; Fleuren GJ; Gorter A; Jordanova ES
Cancer Immunol Immunother; 2015 Jun; 64(6):745-53. PubMed ID: 25795131
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma.
de Vos van Steenwijk PJ; Ramwadhdoebe TH; Goedemans R; Doorduijn EM; van Ham JJ; Gorter A; van Hall T; Kuijjer ML; van Poelgeest MI; van der Burg SH; Jordanova ES
Int J Cancer; 2013 Dec; 133(12):2884-94. PubMed ID: 23740735
[TBL] [Abstract][Full Text] [Related]
9. Wnt5A expression is associated with the tumor metastasis and clinical survival in cervical cancer.
Lin L; Liu Y; Zhao W; Sun B; Chen Q
Int J Clin Exp Pathol; 2014; 7(9):6072-8. PubMed ID: 25337253
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer.
Punt S; Thijssen VL; Vrolijk J; de Kroon CD; Gorter A; Jordanova ES
PLoS One; 2015; 10(6):e0129119. PubMed ID: 26066796
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
García-Martínez E; Gil GL; Benito AC; González-Billalabeitia E; Conesa MA; García García T; García-Garre E; Vicente V; Ayala de la Peña F
Breast Cancer Res; 2014 Nov; 16(6):488. PubMed ID: 25432519
[TBL] [Abstract][Full Text] [Related]
13. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma.
Shi JY; Gao Q; Wang ZC; Zhou J; Wang XY; Min ZH; Shi YH; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Song K; Fan J
Clin Cancer Res; 2013 Nov; 19(21):5994-6005. PubMed ID: 24056784
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
16. Potential value of in situ cellular immune response in HPV subtype 16 and 18 positive cervical cancer.
Ancuţa E; Buţureanu S; Zugun-Eloae F; Anton CR; Ancuţa C; Diţescu D; Anton E
Rom J Morphol Embryol; 2014; 55(3):817-22. PubMed ID: 25329108
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix.
Wu CH; Ko JL; Chen SC; Lin YW; Han CP; Yang TY; Chien MH; Wang PH
Gynecol Oncol; 2014 Feb; 132(2):474-82. PubMed ID: 24316309
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis.
Peng X; Wu Z; Yu L; Li J; Xu W; Chan HC; Zhang Y; Hu L
Gynecol Oncol; 2012 May; 125(2):470-6. PubMed ID: 22366595
[TBL] [Abstract][Full Text] [Related]
20. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
